Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox-9 transcription factor

Rheumatology

Volumn 40, Issue 10, 2001, Pages 1146-1156

  Kolettas, E ^a,c   Muir, H I ^a   Barrett, J C ^b   Hardingham, T E ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Apoptosis; Chondrocytes; Cytokines; Gene expression; Sox9

Indexed keywords

AGGRECAN; BIGLYCAN; CELL PROTEIN; COLLAGEN TYPE 1; CYTOKINE; DNA; INTERLEUKIN 1ALPHA; MESSENGER RNA; RNA; TRANSCRIPTION FACTOR;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTHRITIS; ARTICLE; BIOSYNTHESIS; CARTILAGE CELL; CARTILAGE MATRIX; CATABOLISM; CELL CULTURE; CELL DENSITY; CELL POPULATION; CELL SURVIVAL; CHEMICAL LABELING; CHONDROGENESIS; CONTROLLED STUDY; DOWN REGULATION; EMBRYO CELL; EXTRACTION; GENE EXPRESSION; MOLECULAR WEIGHT; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; SERUM; SYRIAN HAMSTER; TISSUE REPAIR; TISSUE SPECIFICITY; WESTERN BLOTTING;

EID: 0034777927     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/40.10.1146     Document Type: Article

References (74)

1. Toward a molecular understanding of skeletal development
2. Divide, accumulate, differentiate: Cell condensation in skeletal development revisited
3. Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development-transcription factors and signalling pathways
4. Controlled conversion of an immortalized mesodermal progenitor cell towards osteogenic, chondrogenic or adipogenic pathways
5. Combination of osteoinductive bone proteins differentiates mesenchymal C3H/10T1/2 cells specifically to the cartilage lineage
6. Morphological and neoplastic transformation of Syrian hamster embryo fibroblasts by diethylstilbestrol and its analogs
7. Loss of tumour suppressor function during chemically induced neoplastic progression of Syrian hamster embryo cells
8. Loss of tumour suppressor gene function is correlated with downregulation of chondrocyte-specific collagen expression in Syrian hamster embryo cells
9. The chondrocyte, architect of cartilage: Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules
10. An established rat cell line expressing chondrocyte properties
11. Expression of simian virus 40 large T (tumour) oncogene in mouse chondrocytes induces cell proliferation without loss of the differentiated phenotype
12. Coordinate regulation of collagen II (alpha 1) and H19 expression in immortalised hamster cells
13. Expression of cartilage-specific molecules is retained on long-term culture of human articular chondrocytes
14. Establishment of a novel chondrocyte-like cell line derived from transgenic mice harboring the temperature sensitive simian virus 40 large T-antigen gene
15. Sox9 is a potent activator of the chondrocyte-specific enhancer of the proα1(II) collagen gene
16. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene
17. Toward understanding Sox9 function in chondrocyte differentiation
18. The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos
19. Sox9 binds DNA, activates transcription and coexpresses with type II collagen during chondrogenesis in the mouse
20. Sox9 directly regulates the type-II collagen gene
21. Parallel expression of Sox9 and Col2α1 in cells undergoing chondrogenesis
22. Sox9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6
23. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the Sry-related gene Sox9
24. Campomelic dysplasia and autosomal sex reversal caused by mutations in an Sry-related gene
25. A novel germ line mutation in Sox9 causes familial campomelic dysplasia and sex reversal
26. Sex reversal by loss of the C-terminal transactivation domain of human Sox9
27. Sox9 is required for cartilage formation
28. Cartilage degradation
29. Effect of interleukin-1 and insulin-like growth factor-1 on the release of proteoglycan components and hyaluronan from pig articular cartilage in explant culture
30. Cartilage growth and differentiation factors
31. Peptide growth factors and their interactions during chondrogenesis
32. Genetic enhancement of matrix synthesis of articular chondrocytes: Comparison of different growth factor genes in the presence and absence of interleukin-1
33. Insulin-like growth factor-1 blocks collagen release and downregulates matrix metalloproteinase-1, -3, -8 and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha
34. Induction and prevention of chondrocyte hypertrophy in culture
35. Resting chondrocytes in culture survive without growth factors but are sensitive to toxic oxygen metabolites
36. Autocrine signals enable chondrocytes to survive in culture
37. Apoptosis of terminally differentiated chondrocytes in culture
38. Autocrine stimulation by insulin-like growth factor 1 and insulin-like growth factor 2 mediates chondrocyte survival in vitro
39. Purification of mouse immunoglobulin heavy chain messenger RNAs from total myeloma tumour RNA
40. Cloning and characterization of five overlapping cDNAs for the human pro alpha 1(I) collagen chain
41. Expression of the mouse alpha1 (II) collagen gene is not restricted to cartilage during development
42. Molecular cloning of rat and human type (IX) collagen cDNA and localization of the α1(IX) gene on the human chromosome 6
43. The human collagen X gene. Complete primary translated sequence and chromosomal localisation
44. Quantification of aggrecan and link protein mRNA in human articular cartilage of different ages by competitive reverse transcriptase-PCR
45. The primary structure of human cartilage link protein
46. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several non-connective tissue proteins in a variety of species
47. Single and rapid method for the detection of apoptosis in human cells
48. Tissue specific forms of type IX collagen-proteoglycan arise from the use of two widely separated promoters
49. The α1(IX) collagen gene gives rise to two different transcripts in both mouse embryonic and human fetal RNA
50. Versican gene expression in human articular cartilage and comparison of mRNA splicing variation with aggrecan
51. Biosynthesis of small proteoglycan II (decorin) by chondrocytes and evidence for a procore protein
52. Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage
53. Proteoglycan production by immortalized human chondrocyte cell lines cultured under conditions that promote expression of the differentiated phenotype
54. Link protein cDNA sequence reveals tandemly repeated protein structure
55. Regulation of apoptosis by low serum in cells of different stages of neoplastic progression: Enhanced susceptibility after loss of a senescence gene and decreased susceptibility after loss of a tumour suppressor gene
56. Effects of alterations in calcium homeostasis on apoptosis during neoplastic progression
57. Evidence of a direct role for bcl-2 in the regulation of articular chondrocyte apoptosis under the conditions of serum withdrawal and retinoic acid treatment
58. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage
59. Chondrocyte apoptosis induced by aggrecan G1 domain as a result of decreased adhesion
60. Differential expression of a cysteine-rich domain in the amino-terminal propeptide of type II (cartilage) procollagen by alternative splicing of mRNA
61. Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: Differential expression of the amino-propeptide
62. Coexpression of collagens type II and XI and alternative splicing of exon 2 of collagen II in several developing human tissues
63. Preferential expression of alternatively spliced mRNAs encoding type II procollagen with cysteine-rich amino-propeptide in differentiating cartilage and non-chondrogenic tissues during early mouse development
64. Induction of proliferation or hypertrophy of chondrocytes in serum-free culture: The role of insulin-like growth factor 1, insulin or thyroxine
65. Serum induction of the collagen type X promoter requires the Raf/MEK/ERK and p38 pathways
66. Regulation and role of Sox9 in cartilage formation
67. Transcriptional mechanisms of chondrocyte differentiation
68. Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage
69. Interleukin-1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes
70. Transcriptional suppression by interleukin-1 and interferon-γ of type II collagen gene expression in human chondrocytes
71. Interleukin-1 induced suppression of type II collagen gene transcription involves DNA regulatory elements
72. Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumour necrosis factor-1
73. Social controls on cell survival and cell death
74. Constitutive expression of the machinery for cell death